Publisher Correction: Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis

Key Points

• Pancreatic cancer susceptibility relates to specific genetic variations in complement system genes, influencing outcomes.
• Key evidence illustrates how specific biomarkers can indicate both risk and prognosis in pancreatic cancer.
• Assessment focuses on the role of genetic variations in affecting the complement system related to pancreatic cancer.
• These findings may enable better risk assessment and targeted therapies, with the necessity for further validation.